Stockholm3 test complements prostate cancer diagnostics

Stockholm3 test (STHLM3) is a blood test by means of which it is possible to assess the risk of prostate cancer better than with a mere PSA test.

What is the STHLM3 test?

Stockholm3 test (STHLM3) is a blood test by means of which it is possible to assess the risk of prostate cancer better than with a mere PSA test. STHLM3 reveals the cancer risk even lower PSA values (1,5-3 ng/ml) and reduces the number of prostate biopsies, i.e. tissue samples. If the STHLM3 test result is negative, a tissue sample need not necessarily be taken even if PSA was elevated (> 3 ng/ml). Furthermore, STHLM3 is an efficient test for distinguishing between aggressive prostate cancer and more benign cancer.

The STHLM3 test combines information from five protein markers (total PSA, free PSA, hK2, MSMB and MIC-1), more than a hundred genetic tracers and clinical data (age, previous tissue samples, family history in prostate cancer, and, in some cases, an assessment of the structure and size of the prostate by a physician).

The tests are taken in cooperation with Karolinska University Hospital in Sweden, which is the developer of the test. The STHLM3 test has been assessed in a survey of almost 60,000 Swedish men, and the results have been published in the Lancet Oncology magazine in 2015 (Lancet 2015. Vol 16, no 16. p. 1667–1676).

For whom?

The STHLM3 test could replace the PSA test in all men aged 50–70. Furthermore, the STHLM3 test can be taken in cases when the PSA value is > 1,5.

STHLM3 is not suitable for men previously diagnosed with or cured of prostate cancer.

You can apply for the test directly from our appointments service.

How does the STHLM3 test work?

The STHLM3 test is a normal blood sample. The patient receives the test result from Karolinska Hospital. The result indicates the risk of prostate cancer on a risk scale—reduced, normal or elevated—and issues a clear recommendation for further examinations and/or follow-up.

Diagnostics develops continuously

The recommendations issued on the basis of the STHLM3 result may change as new research reveals more information.

Read more

Published: 07.01.2022

One type of cancer is distinct from others due to its painfulness—these everyday methods can alleviate the pain, and sauna is not necessarily one of them

As cancer becomes metastasised, it typically causes more pain. Oncologist Olga Maslennikova from Docrates Cancer Center shares the best ways...

Read more
Published: 20.12.2021

Christmas and public holiday opening hours

Docrates is open, and we are here for you even during Christmas time. See our Christmas and public holiday opening...

Read more
Published: 16.12.2021

Confusion and fear of death are present when a cancer diagnosis is made

Looking after the mental well-being of someone who has been diagnosed with cancer is an essential part of recovery from...

Read more
Published: 13.12.2021

Physical activity can improve the quality of life of cancer patients and the effectiveness of cancer drugs

Physical activity can considerably improve cancer patients’ quality of life. “Improvement in the quality of life was clearly demonstrated in...

Read more

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay even during epidemic.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
358 10 773 2010

Contact us!

Mon-Thu 8 am-6 pm, Fri 8 am-4 pm (GMT +2)